Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

William Clay Faquin, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by William Faquin and Leif Ellisen.
Connection Strength

0.292
  1. FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J Clin Invest. 2013 Aug; 123(8):3525-38.
    View in: PubMed
    Score: 0.141
  2. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res. 2006 Oct 01; 66(19):9362-8.
    View in: PubMed
    Score: 0.088
  3. Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1181-8.
    View in: PubMed
    Score: 0.037
  4. Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2009 Mar 01; 15(5):1645-54.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.